
Dave Trong Nguyen
Supervisory Patent Examiner (ID: 2395, Phone: (571)272-0731 , Office: P/1634 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1804, 1621, 1634, 1632 |
| Total Applications | 624 |
| Issued Applications | 320 |
| Pending Applications | 143 |
| Abandoned Applications | 162 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4309352
[patent_doc_number] => 06316260
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/294035
[patent_app_country] => US
[patent_app_date] => 1999-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7767
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316260.pdf
[firstpage_image] =>[orig_patent_app_number] => 294035
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/294035 | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof | Apr 18, 1999 | Issued |
| 09/290732 | ADENOVIRAL VECTORS FOR TREATING DISEASE | Apr 12, 1999 | Abandoned |
Array
(
[id] => 4322405
[patent_doc_number] => 06319496
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/287221
[patent_app_country] => US
[patent_app_date] => 1999-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13320
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319496.pdf
[firstpage_image] =>[orig_patent_app_number] => 287221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/287221 | Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof | Apr 5, 1999 | Issued |
Array
(
[id] => 7636957
[patent_doc_number] => 06379698
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Fusogenic lipids and vesicles'
[patent_app_type] => B1
[patent_app_number] => 09/287175
[patent_app_country] => US
[patent_app_date] => 1999-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8415
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/379/06379698.pdf
[firstpage_image] =>[orig_patent_app_number] => 09287175
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/287175 | Fusogenic lipids and vesicles | Apr 5, 1999 | Issued |
Array
(
[id] => 1560138
[patent_doc_number] => 06436908
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Use of exogenous -adrenergic receptor and -adrenergic receptor kinase gene constructs to enhance myocardial function'
[patent_app_type] => B1
[patent_app_number] => 09/285677
[patent_app_country] => US
[patent_app_date] => 1999-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 12907
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436908.pdf
[firstpage_image] =>[orig_patent_app_number] => 09285677
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/285677 | Use of exogenous -adrenergic receptor and -adrenergic receptor kinase gene constructs to enhance myocardial function | Apr 4, 1999 | Issued |
Array
(
[id] => 4338751
[patent_doc_number] => 06284256
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Bordetella bronchiseptica vaccine'
[patent_app_type] => 1
[patent_app_number] => 9/281221
[patent_app_country] => US
[patent_app_date] => 1999-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 8785
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284256.pdf
[firstpage_image] =>[orig_patent_app_number] => 281221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/281221 | Bordetella bronchiseptica vaccine | Mar 29, 1999 | Issued |
Array
(
[id] => 4314651
[patent_doc_number] => 06316597
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Sox-9 gene and protein and use in the regeneration of bone or cartilage'
[patent_app_type] => 1
[patent_app_number] => 9/281476
[patent_app_country] => US
[patent_app_date] => 1999-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 15577
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316597.pdf
[firstpage_image] =>[orig_patent_app_number] => 281476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/281476 | Sox-9 gene and protein and use in the regeneration of bone or cartilage | Mar 29, 1999 | Issued |
Array
(
[id] => 6623835
[patent_doc_number] => 20020016304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'CARRIER FOR STABILIZING NUCLEIC ACID'
[patent_app_type] => new
[patent_app_number] => 09/267608
[patent_app_country] => US
[patent_app_date] => 1999-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10375
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09267608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/267608 | CARRIER FOR STABILIZING NUCLEIC ACID | Mar 14, 1999 | Abandoned |
| 09/266463 | MICROPARTICLES FOR DELIVERY OF NUCLEIC ACID | Mar 10, 1999 | Abandoned |
Array
(
[id] => 1245584
[patent_doc_number] => 06677152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene'
[patent_app_type] => B2
[patent_app_number] => 09/263178
[patent_app_country] => US
[patent_app_date] => 1999-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 13990
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677152.pdf
[firstpage_image] =>[orig_patent_app_number] => 09263178
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/263178 | Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene | Mar 4, 1999 | Issued |
Array
(
[id] => 6128332
[patent_doc_number] => 20020076394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'DELIVERY SYSTEM FOR GENE THERAPY TO THE BRAIN'
[patent_app_type] => new
[patent_app_number] => 09/202564
[patent_app_country] => US
[patent_app_date] => 1999-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7477
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076394.pdf
[firstpage_image] =>[orig_patent_app_number] => 09202564
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202564 | Delivery system for gene therapy to the brain | Feb 7, 1999 | Issued |
Array
(
[id] => 1452627
[patent_doc_number] => 06461641
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Tumor delivery vehicles'
[patent_app_type] => B1
[patent_app_number] => 09/243756
[patent_app_country] => US
[patent_app_date] => 1999-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6676
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461641.pdf
[firstpage_image] =>[orig_patent_app_number] => 09243756
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/243756 | Tumor delivery vehicles | Feb 2, 1999 | Issued |
Array
(
[id] => 1532192
[patent_doc_number] => 06410328
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Sensitizing cells to compounds using lipid-mediated gene and compound delivery'
[patent_app_type] => B1
[patent_app_number] => 09/243104
[patent_app_country] => US
[patent_app_date] => 1999-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 12910
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410328.pdf
[firstpage_image] =>[orig_patent_app_number] => 09243104
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/243104 | Sensitizing cells to compounds using lipid-mediated gene and compound delivery | Feb 1, 1999 | Issued |
Array
(
[id] => 7040821
[patent_doc_number] => 20010005505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-06-28
[patent_title] => 'DESTRUCTION OF THE EPITHELIUM OF AN EXOCRINE GLAND IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF CANCER'
[patent_app_type] => new-utility
[patent_app_number] => 09/240206
[patent_app_country] => US
[patent_app_date] => 1999-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5720
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20010005505.pdf
[firstpage_image] =>[orig_patent_app_number] => 09240206
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/240206 | Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancer | Jan 28, 1999 | Issued |
Array
(
[id] => 4324147
[patent_doc_number] => 06312683
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Equine infectious anemia virus vectors'
[patent_app_type] => 1
[patent_app_number] => 9/238356
[patent_app_country] => US
[patent_app_date] => 1999-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 38
[patent_no_of_words] => 28464
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312683.pdf
[firstpage_image] =>[orig_patent_app_number] => 238356
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/238356 | Equine infectious anemia virus vectors | Jan 26, 1999 | Issued |
Array
(
[id] => 4403999
[patent_doc_number] => 06264941
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules'
[patent_app_type] => 1
[patent_app_number] => 9/236246
[patent_app_country] => US
[patent_app_date] => 1999-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22603
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/264/06264941.pdf
[firstpage_image] =>[orig_patent_app_number] => 236246
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/236246 | Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Jan 24, 1999 | Issued |
Array
(
[id] => 7629730
[patent_doc_number] => 06818626
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-16
[patent_title] => 'Chelating systems for use in the delivery of compounds to cells'
[patent_app_type] => B1
[patent_app_number] => 09/234606
[patent_app_country] => US
[patent_app_date] => 1999-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10554
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818626.pdf
[firstpage_image] =>[orig_patent_app_number] => 09234606
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/234606 | Chelating systems for use in the delivery of compounds to cells | Jan 20, 1999 | Issued |
Array
(
[id] => 1600900
[patent_doc_number] => 06475995
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Oral delivery of nucleic acid vaccines by particulate complexes'
[patent_app_type] => B1
[patent_app_number] => 09/232167
[patent_app_country] => US
[patent_app_date] => 1999-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 9661
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475995.pdf
[firstpage_image] =>[orig_patent_app_number] => 09232167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/232167 | Oral delivery of nucleic acid vaccines by particulate complexes | Jan 14, 1999 | Issued |
Array
(
[id] => 1594124
[patent_doc_number] => 06383814
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Cationic amphiphiles for intracellular delivery of therapeutic molecules'
[patent_app_type] => B1
[patent_app_number] => 09/228232
[patent_app_country] => US
[patent_app_date] => 1999-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 28
[patent_no_of_words] => 25760
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/383/06383814.pdf
[firstpage_image] =>[orig_patent_app_number] => 09228232
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/228232 | Cationic amphiphiles for intracellular delivery of therapeutic molecules | Jan 10, 1999 | Issued |
Array
(
[id] => 4302694
[patent_doc_number] => 06326195
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Recombinant retroviral vector'
[patent_app_type] => 1
[patent_app_number] => 9/225509
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12666
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326195.pdf
[firstpage_image] =>[orig_patent_app_number] => 225509
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225509 | Recombinant retroviral vector | Jan 5, 1999 | Issued |